Ftse Mib
36.448,91
0,21%
DAX
21.706,90
0,39%
S&P 500
6.039,31
-0,47%
NASDAQ
19.632,32
-0,51%
Bitcoin
105.053,01
1,27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Eli Lilly and Co (LLY) Eli Lilly and Co (LLY) Notizie

Eli Lilly and Co

LLY
804,08
0,00 (0,00%)
30 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/1/202521:54EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
23/1/202522:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202516:00PRNUSLilly confirms date and conference call for fourth-quarter..
15/1/202522:06PRNUSFDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's..
14/1/202515:05EDGAR2Form 8-K - Current report
14/1/202515:00PRNUSLilly provides update on 2024 revenue guidance, announces..
13/1/202515:00PRNUSLilly to acquire Scorpion Therapeutics' mutant-selective..
07/1/202516:00PRNUSLilly to participate in J.P. Morgan Healthcare Conference
20/12/202422:32PRNUSFDA approves Zepbound® (tirzepatide) as the first and only..
18/12/202402:00PRNUSLilly's Kisunla™ (donanemab-azbt) Approved in China for the..
17/12/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202412:00PRNUSLilly and EVA Pharma announce regulatory approval and..
13/12/202414:11PRNUSLilly's Omvoh® (mirikizumab) recommended by CHMP for..
11/12/202414:15PRNUSLilly's Imlunestrant, an Oral SERD, Significantly Improved..
09/12/202423:45PRNUSPhase 3 results for Lilly's Jaypirca® (pirtobrutinib) in..
09/12/202422:17PRNUSLilly announces new $15 billion share repurchase program and..
09/12/202415:00PRNUSCORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up..
05/12/202421:30PRNUSLilly announces $3 billion expansion of its recently..
04/12/202422:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/12/202412:45PRNUSLilly's Zepbound® (tirzepatide) superior to Wegovy®..
20/11/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202411:00GLOBEVerge Genomics Announces Milestones in Collaboration with..
19/11/202422:49EDGAR2Form 8-K - Current report
19/11/202422:30PRNUSLilly announces changes on board of directors
18/11/202420:52PRNUSLilly's muvalaplin lowered lipoprotein(a) levels in adults..
16/11/202416:00PRNUSLilly's tirzepatide reduced the risk of worsening heart..
15/11/202401:00EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202423:05PRNUSTreatment with tirzepatide in adults with pre-diabetes and..
08/11/202422:54EDGAR2Form 144 - Report of proposed sale of securities
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202415:04PRNUSLilly announces details of presentations at the 2024..
Apertura: Min: Max:
Chiusura: 804,08

La tua Cronologia

NYSE
LLY
Eli Lilly
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci